Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT00960843




Registration number
NCT00960843
Ethics application status
Date submitted
14/08/2009
Date registered
18/08/2009
Date last updated
20/08/2012

Titles & IDs
Public title
Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety
Scientific title
A Randomized, Controlled, 6-month Study to Compare the Effects of Volume- and Pressure-guided Adjustments on Weight Loss and Satiety in Patients Implanted With the Swedish Adjustable Gastric Band
Secondary ID [1] 0 0
CI-08-0009
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Morbid Obesity 0 0
Condition category
Condition code
Diet and Nutrition 0 0 0 0
Obesity
Metabolic and Endocrine 0 0 0 0
Other metabolic disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Intraband pressure recording system
Other interventions - Conventional Adjustment

Active comparator: Conventional Adjustment Group - Subject whose band adjustments will be made via conventional standard of care (e.g., volume, hunger).

Active comparator: Intraband Pressure Arm - Subjects whose band adjustments will be guided by intraband pressure readings.


Treatment: Devices: Intraband pressure recording system
Intraband pressure will be measured by a pressure recording system.

Other interventions: Conventional Adjustment
Band adjustments will be made via conventional standard of care (e.g., volume, hunger).
Intervention code [1] 0 0
Treatment: Devices
Intervention code [2] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percent Excess Weight Change at Day 180
Timepoint [1] 0 0
Screening to Day 180
Secondary outcome [1] 0 0
Mean Static Intraband Pressure at Day 180
Timepoint [1] 0 0
Day 180
Secondary outcome [2] 0 0
Rate of Weight Loss kg/wk at Day 180
Timepoint [2] 0 0
Screening to Day 180

Eligibility
Key inclusion criteria
* Able to comprehend, follow and give informed consent.
* Be at least 18 years of age at time of trial enrollment.
* Had a pre-implantation BMI between 35 and 55 kg/m2.
* Have received a SAGB VC implant 1) 30-60 days (and not undergone first band adjustment yet)prior to the date of enrollment.
* Willingness to be randomized to intraband-based or conventional adjustments
* Willingness to consent to monthly visits and possible measurements of intraband pressure (requiring access to the injection port).
* Willingness to undergo up to 7 band adjustments within the 6-month period of the study.
* Able to sit approximately at a 90 degree-angle, from the floor, for IBP measurements.
* Willingness to return to office visits around the same time of the first in-study adjustment (plus or minus 2 hours)
* Willingness to consent to a limited UGI series if the investigator suspects the presence of a band-related complication or if the intraband pressure recordings deviate from expected.
* Willingness to refrain from taking medications or supplements indicated for or known to induce weight loss.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Females currently known to be pregnant.
* Ongoing or unresolved band perforation or band leakage.
* Ongoing (unresolved) slippage, erosion, or pouch dilation.
* Documented esophageal dysmotility/dyskinesia.
* Ongoing (unresolved) port obstruction or tube kinking.
* Current injection port infection.
* History of band revision or replacement.
* Previously documented or ongoing esophageal dilatation.
* Any condition that, in the opinion of the Investigator, may jeopardize the subject's well-being or the soundness of this study.
* Current use of medications or supplements indicated for or known to induce weight loss at any point during the study.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/07/2009
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/11/2010
Sample size
Target
Accrual to date
Final
51
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 0 0
Adelaide Bariatric Center - Bedford Park
Recruitment postcode(s) [1] 0 0
5042 - Bedford Park
Recruitment outside Australia
Country [1] 0 0
Czech Republic
State/province [1] 0 0
Prague

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Ethicon Endo-Surgery
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this protocol is to determine how band fill volumes that are based on intraband pressure readings can influence the comfortability of the band and to compare weight loss with this methodology to weight loss with the conventional approach recommended in existing product labeling.
Trial website
https://clinicaltrials.gov/study/NCT00960843
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT00960843